Last updated: March 18, 2024
Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pregnancy Complications
Treatment
N/AClinical Study ID
NCT06281366
PR(AMI)470-2023
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Single pregnancy
- Maternal age ≥18
- High risk (≥1/50) in the first-trimester screening for preeclampsia
- Gestational age between 11+0 and 16+6 weeks of gestation
Exclusion
Exclusion Criteria:
- Fetal malformation
- Fetal death
- Maternal digestive inflammatory disease or intolerance
- Refusal to give informed consent
Study Design
Total Participants: 75
Study Start date:
February 16, 2024
Estimated Completion Date:
December 31, 2025
Connect with a study center
Manel Mendoza
Barcelona, 08035
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.